TLDR Allopregnanolone changes gene expression in glioblastoma cells.
The study investigated the effects of allopregnanolone (3α-THP), progesterone (P4), and finasteride (F) on gene expression in U87 human glioblastoma cells, revealing that 3α-THP significantly altered 137 genes, F changed 90, and P4 modified only six. Both 3α-THP and F up-regulated genes involved in DNA integrity, replication, and cytoskeleton reorganization. The study validated changes in 10 selected genes, with 3α-THP up-regulating six. Combined treatments showed distinct gene expression changes, suggesting F modulates the effects of P4 and 3α-THP. The findings highlighted the potential of 3α-THP and F in influencing glioblastoma cell behavior and suggested further research to explore their clinical applications.
25 citations,
March 2017 in “Steroids” Allopregnanolone increases growth and changes gene activity in human brain cancer cells.
7 citations,
June 2015 in “The American Journal of the Medical Sciences” Finasteride helps reduce blood vessel growth in diabetic rat kidneys.
12 citations,
October 2013 in “The Prostate” Dutasteride and finasteride affect different cell types differently.
218 citations,
December 2011 in “Advances in Urology” The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.
37 citations,
January 2009 in “Sexual Development” Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.
25 citations,
March 2017 in “Steroids” Allopregnanolone increases growth and changes gene activity in human brain cancer cells.
223 citations,
December 2010 in “The Journal of Sexual Medicine” Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.
1 citations,
January 2019 in “Elsevier eBooks” Neuroactive steroids may affect the risk and treatment of alcohol use disorders.
123 citations,
December 2015 in “Journal of Neuroendocrinology” New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.
65 citations,
January 2011 in “Frontiers in Endocrinology” Neurosteroids show promise for treating epilepsy and more research is needed.
